Seminars in Cancer Biology

Introduction: innate host antitumor immunity and tumor progression
pp. 259-260(2)
Author: Deichman G.I.

Tumor progression: a brief historical perspective
pp. 261-266(6)
Author: Nowell P.C.

Implication of direct host–tumor intercellular interactions in non-immune host resistance to neoplastic growth
pp. 267-276(10)
Author: Krutovskikh V.

Interleukin-1—a major pleiotropic cytokine in tumor–host interactions
pp. 277-290(14)
Authors: Apte R.N.; Voronov E.

Mechanisms of immune privilege for tumor cells by regulatory cytokines produced by innate and acquired immune cells
pp. 291-300(10)
Authors: Seo N.; Hayakawa S.; Tokura Y.

Dendritic cells, antigen distribution and the initiation of primary immune responses to self and non-self antigens
pp. 301-308(8)
Authors: Knight S.C.; Burke F.; Bedford P.A.

The biological role of the Fas/FasL system during tumor formation and progression
pp. 309-315(7)
Author: Reichmann E.

Early phenotypic changes of in vitro transformed cells during in vivo progression: possible role of the host innate immunity
pp. 317-326(10)
Author: Deichman G.I.